Results 41 to 50 of about 4,554 (207)

Stereotactic radiotherapy for oligometastases in the lymph nodes

open access: yesReports of Practical Oncology and Radiotherapy, 2022
Even though systemic therapy is standard treatment for lymph node metastases, metastasis-directed stereotactic radiotherapy (SRT ) seems to be a valid option in oligometastatic patients with a low disease burden. Positron emission tomography-computed tomography (PET-CT ) is the gold standard for assessing metastases to the lymph nodes; co-registration ...
Pasqualetti F.   +7 more
openaire   +3 more sources

Stereotactic Body Radiotherapy for Lymph Node Oligometastases: Real-World Evidence From 90 Consecutive Patients

open access: yesFrontiers in Oncology, 2021
AimsTo evaluate the efficacy and toxicity of extracranial stereotactic body radiotherapy (SBRT) in the treatment of oligometastatic lymph node involvement in the mediastinum, retroperitoneum, or pelvis, in a consecutive group of patients from real ...
Petr Burkon   +17 more
doaj   +1 more source

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5

open access: yesBMC Cancer, 2018
Background Oligometastases refer to a state of disease where cancer has spread beyond the primary site, but is not yet widely metastatic, often defined as 1–3 or 1–5 metastases in number.
Robert Olson   +19 more
doaj   +1 more source

Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options

open access: yesCurrent Oncology, 2021
Introduction: Recent modifications in the epidemiology of oropharyngeal squamous cell carcinoma (OSCC) have led to the increase of Human papillomavirus (HPV) related metastatic head and neck cancer patients with high life expectancy even at advanced ...
Anouchka Modesto   +8 more
doaj   +1 more source

Effective Systemic Treatment of Choroidal Metastases NSCLC With Surgery After Crizotinib: A Case Report

open access: yesFrontiers in Oncology, 2022
Choroidal metastasis as an initial presenting feature of lung cancer with EML4-ALK translocation is exceedingly rare and greatly impacts patient quality of life (QOL).
Shilan Liu   +12 more
doaj   +1 more source

Bibliometric Analysis of the Top-Cited Publications and Research Trends for Stereotactic Body Radiotherapy

open access: yesFrontiers in Oncology, 2021
ObjectiveThis study aims to analyze the 100 most cited papers and research trends on stereotactic body radiotherapy (SBRT).MethodsWe used Web of Science to identify the 100 most frequently cited papers on SBRT on September 29, 2021 and extracted the ...
Yanhao Liu   +3 more
doaj   +1 more source

Multicenter Retrospective Study of the Impact of Localized Therapy on Prognosis in Patients With Oligometastatic Solid Tumors

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Local therapy has recently been applied to treat oligometastatic cancer across various malignant cancers. However, definitive evidence for local treatment regimens remains lacking. We aimed to evaluate the clinical outcomes of combining local therapy with systemic treatment for patients with oligometastatic solid tumors including ...
Xueman Deng   +6 more
wiley   +1 more source

Serous Ovarian Carcinoma Presenting With Synchronous Breast Metastasis: A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Synchronous breast metastasis from ovarian cancer is exceptionally rare. A 53‐year‐old woman with FIGO IIIC high‐grade serous ovarian carcinoma underwent cytoreductive surgery, chemotherapy, and breast radiotherapy. Immunohistochemistry confirmed metastatic disease.
Ramesh Omranipour   +5 more
wiley   +1 more source

Improvement of long-term treatment results in oligometastatic colorectal cancer patients by using a combined approach

open access: yesЮжно-Российский онкологический журнал
Purpose of the study. To improve the treatment results of patients suffering from CRC with oligometastatic lesion by determining the most effective combination of treatment methods.Patients and methods.
E. O. Kalmykova   +3 more
doaj   +1 more source

Volumetric Modulated Arc Therapy for lung cancer: Correlation between dose and volume

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 10, October 2026.
Abstract Background In lung cancer radiotherapy, the volume of the lung receiving a dose above 20 Gy (V20Gy) and the mean lung dose are widely recognized dosimetric indicators for predicting radiation pneumonitis. However, there is currently no unified model to predict the minimum achievable values of V20Gy and mean lung dose.
Yu Wang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy